Aberrant RNA processing events in neurological disorders

被引:67
|
作者
Anthony, Karen [1 ]
Gallo, Jean-Marc [1 ]
机构
[1] Kings Coll London, MRC Ctr Neurodegenerat Res, Inst Psychiat, Dept Clin Neurosci, London SE5 8AF, England
关键词
RNA processing; Neurodegeneration; RNA-binding protein; AMYOTROPHIC-LATERAL-SCLEROSIS; OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; PRE-MESSENGER-RNA; AMPA RECEPTOR SUBUNIT; FRAGILE-X-SYNDROME; FRONTOTEMPORAL LOBAR DEGENERATION; ELONGATION-FACTOR; 1-ALPHA; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; BINDING-PROTEIN;
D O I
10.1016/j.brainres.2010.03.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The importance of aberrant RNA processing in neurodegeneration is becoming increasingly clear; a recent example being the identification of the splicing factor TDP-43 as the major component of inclusions characteristic of a number of neurodegenerative conditions including amyotrophic lateral sclerosis (ALS). Due to the enormous diversity generated by alternative splicing and its importance in the nervous system, it is no surprise that defective alternative splicing in disease has been particularly well documented. However, in addition to splicing, other RNA processing events such as RNA editing, polyadenylation and mRNA stability are also disrupted in some neurological disorders. For instance: the editing efficiency of specific ionotropic receptors is reduced in ALS affecting ion permeability and the function of RNA-processing proteins is affected by their sequestration to trinucleotide repeat expanded mRNAs in several disorders. Due to the extensive coupling between RNA processing events and the multifunctionality of the RNA processing factors that regulate them, it is important to consider RNA processing as a whole. Here we review RNA processing events and their extensive coupling to one another and detail the associations of RNA processing including, but not exclusively, alternative splicing with neurodegeneration. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 50 条
  • [31] Brain somatic mutations as RNA therapeutic targets in neurological disorders
    Lee, Sungyul
    Lee, Jeong Ho
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2022, 1514 (01) : 11 - 20
  • [33] Detection of aberrant splicing events in RNA-seq data using FRASER
    Mertes, Christian
    Scheller, Ines F.
    Yepez, Vicente A.
    Celik, Muhammed H.
    Liang, Yingjiqiong
    Kremer, Laura S.
    Gusic, Mirjana
    Prokisch, Holger
    Gagneur, Julien
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [34] Detection of aberrant splicing events in RNA-seq data using FRASER
    Christian Mertes
    Ines F. Scheller
    Vicente A. Yépez
    Muhammed H. Çelik
    Yingjiqiong Liang
    Laura S. Kremer
    Mirjana Gusic
    Holger Prokisch
    Julien Gagneur
    Nature Communications, 12
  • [35] Overall Role of Contactins Expression in Neurodevelopmental Events and Contribution to Neurological Disorders
    Bizzoca, Antonella
    Jirillo, Emilio
    Flace, Paolo
    Gennarini, Gianfranco
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (08) : 1176 - 1193
  • [36] Aberrant splicing in neurological diseases
    Feng, Dairong
    Xie, Jiuyong
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2013, 4 (06) : 631 - 649
  • [37] RNA transport and localized protein synthesis in neurological disorders and neural repair
    Wang, Wenlan
    van Niekerk, Erna
    Willis, Dianna E.
    Twiss, Jeffery L.
    DEVELOPMENTAL NEUROBIOLOGY, 2007, 67 (09) : 1166 - 1182
  • [38] Circular RNA-Derived Micropeptides at the Synapse: Potential New RNA Therapeutics for Neurological Disorders
    Bredy, Timothy
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 58 - 58
  • [39] Long Non-coding RNA in Neuronal Development and Neurological Disorders
    Li, Ling
    Zhuang, Yingliang
    Zhao, Xingsen
    Li, Xuekun
    FRONTIERS IN GENETICS, 2019, 9
  • [40] FHIT and TSG101 in thyroid tumours:: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance
    McIver, B
    Grebe, SKG
    Wang, L
    Hay, ID
    Yokomizo, AA
    Liu, WG
    Goellner, JR
    Grant, CS
    Smith, DI
    Eberhardt, NL
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 749 - 757